Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
National
Matt Mathers

UK speeds up plans to develop mRNA vaccines for cancer patients with BioNTech deal

Getty Images

Cutting-edge research into developing personalised mRNA vaccines for cancer patients will be accelerated following the UK’s successful Covid-jab rollout.

BioNTech, the German firm that co-produced a Covid vaccine with Pfizer, will partner with the government to deliver 10,000 personalised therapies to patients in the UK by 2030.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.